Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection

Stephanos J. Hadziyannis – 1 May 1988 – A controlled trial of lymphoblastoid interferon versus no therapy in patients positive for HBsAg, HBeAg and DNA polymerase activity with separate randomisation for sexual preference and histology is underway. Thirty‐two patients have been followed for a minimum period of 6 months of whom 15 have been randomised to receive interferon thrice weekly for 6 months after a 5‐day induction phase.

Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis

Ulrich Spengler, Gerd R. Pape, Robert M. Hoffmann, Judith P. Johnson, Josef Eisenburg, Gustav Paumgartner, Gert Riethmüller – 1 May 1988 – To study the expression of MHC Class II subregion gene products on biliary epithelial cells in primary biliary cirrhosis, frozen sections from liver biopsies of 15 patients with primary biliary cirrhosis were studied immunohistochemically using HLA‐D subregion specific monoclonal antibodies L243 (HLA‐DR), Leu10 (HLA‐DQ) and B7/21 (HLA‐DP).

Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction

Pere Ginès, Wladimiro Jiménez, Vicente Arroyo, Miquel Navasa, Clara López, Llúcia Titó, Antoni Serra, Jaime Bosch, Ginès Sanz, Francisca Rivera, Joan Rodés – 1 May 1988 – The aim of this study was to determine the plasma levels, cardiac release and splanchnic extraction of atrial natriuretic factor in cirrhosis with ascites. The plasma concentration of immunoreactive atrial natriuretic factor in samples obtained from an antecubital vein was measured in 18 healthy volunteers and in 35 cirrhotics with ascites.

Percutaneous portal‐systemic shunts: Promise and problems

David S. Zimmon – 1 May 1988 – Original Gianturco expandable stents and their modifications were used to create an experimental intra‐hepatic portacaval anastomosis (EIPCA) in 30 young domestic swine without portal hypertension. The study focused on the design of a suitable stent, the technique of its application, the the evaluation of short‐term patency of the EIPCA. A stent with a 2.5‐cm‐long body and wire skirts on both ends was most suitable for EIPCA creation.

The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts

Martin Hoerner, Ursula J. Behrens, Theresa M. Worner, Ileen Blacksberg, Lawrence F. Braly, Fenton Schaffner, Charles S. Lieber – 1 May 1988 – We recently presented preliminary data indicating the presence of antibodies against acetaldehyde adducts in sera of over 70% of alcoholic patients. To assess the respective roles of liver disease and alcohol consumption as well as the specificity of this immune response, 141 patients in various stages of alcoholic and nonalcoholic liver diseases were tested by a hemagglutination assay.

Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis

Rolf Joeres, Hartwig Klinker, Hermann Heusler, Johannes Epping, Walter Zilly, Ernst Richter – 1 May 1988 – The effect of smoking on caffeine elimination was measured in 7 healthy volunteers and in 18 smoking and in 30 nonsmoking patients with alcoholic liver cirrhosis following oral application of 366 mg caffeine. In an intraindividual experiment in smoking healthy probands, caffeine clearance decreased from 118 ± 33 to 77 ± 22 ml per min (p < 0.05) after abstaining cigarette smoking for 3 weeks.

Oxidant stress during reperfusion of ischemic liver: No evidence for a role of xanthine oxidase

Jacques Metzger, Srinath P. Dore, Bernhard H. Lauterburg – 1 May 1988 – Oxygen‐derived free radicals might play a role in the injury produced by reperfusion of ischemic organs. Since the generation of reactive oxygen species results in an increased formation of glutathione disulfide, we have attempted to document an oxidant stress during reperfusion of ischemic liver by following the hepatic production of glutathione disulfide in vivo and in the perfused rat liver.

Ethinylestradiol stimulates a biliary cholesterol‐phospholipid cosecretion mechanism in the hamster

Frieder Berr, Frans Stellaard, Alwin Goetz, Claus Hammer, Gustav Paumgartner – 1 May 1988 – The mechanism of ethinylestradiol‐induced biliary secretion of excess cholesterol, a potential causative factor of cholesterol gallstones, is not yet known. It might be related to altered bile acid metabolism, since the rate of cholesterol and phospholipid secreted into bile is thought to be influenced by the hydrophobicity of the bile acid species secreted.

Subscribe to